Literature DB >> 25682367

Quality of life in a community sample of young cocaine and/or heroin users: the role of mental disorders.

M Chahua1, A Sánchez-Niubò, M Torrens, L Sordo, M J Bravo, M T Brugal, A Domingo-Salvany.   

Abstract

PURPOSE: Drug addiction and psychiatric disorders are frequently concomitant; however, few studies have investigated the impact of psychiatric disorders other than substance use disorder (SUD) on health-related quality of life (HRQoL) in drug users not in treatment. We studied the association of psychiatric disorders other than SUD with HRQoL in a street-recruited sample of cocaine and/or heroin users.
METHODS: It is a cross-sectional study involving 287 young users of cocaine and/or heroin in Barcelona, Spain. HRQoL was assessed with the Nottingham health profile (NHP). Patterns of drug use and mental disorders were assessed using the Spanish version of the psychiatric research interview for substance and mental disorders IV, and degree of dependence through the severity of dependence scale (SDS). The association of mental disorders with HRQoL was assessed through a Tobit regression analysis.
RESULTS: The overall NHP score was 23.9 (SD = 20.5, range 0-91.7). Sixty-one percent of the sample had two or more SUDs; 22 % had at least one non-SUD Axis I disorder (anxiety, mood, psychotic, or eating disorder); and 27.2 % had a borderline personality disorder (BPD) and/or antisocial personality disorder. Variables negatively associated with the global NHP score were psychosis [transformed beta coefficient: 15.23; 95 % confidence interval [CI] 4.48-25.97], BPD (9.55; 95 % CI 2.95-16.15), severity of dependence (8.12; 95 % CI 3.37-12.87), having two or more SUDs (for two or three SUDs: 6.83; 95 % CI 2.08-11.59) (>3 SUDs: 7.70; 95 % CI 1.72-13.68) and the intravenous use of some substance (10.20; 95 % CI 6.00-14.40).
CONCLUSION: HRQoL among street-recruited illegal substance users was impaired, particularly among those with psychiatric comorbidity, psychosis, and BPD being especially relevant.

Entities:  

Mesh:

Year:  2015        PMID: 25682367     DOI: 10.1007/s11136-015-0943-5

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  51 in total

Review 1.  The validity of self-reports of alcohol consumption: state of the science and challenges for research.

Authors:  Frances K Del Boca; Jack Darkes
Journal:  Addiction       Date:  2003-12       Impact factor: 6.526

2.  SNOWBALL VERSUS RESPONDENT-DRIVEN SAMPLING.

Authors:  Douglas D Heckathorn
Journal:  Sociol Methodol       Date:  2011-08-01

3.  Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis.

Authors:  Shaun M Eack; Christina E Newhill
Journal:  Schizophr Bull       Date:  2007-01-04       Impact factor: 9.306

4.  Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment.

Authors:  M Torrens; L San; A Martinez; C Castillo; A Domingo-Salvany; J Alonso
Journal:  Addiction       Date:  1997-06       Impact factor: 6.526

5.  Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders.

Authors:  Stephen T Tiffany; Lawrence Friedman; Shelly F Greenfield; Deborah S Hasin; Ron Jackson
Journal:  Addiction       Date:  2011-10-07       Impact factor: 6.526

6.  The Spanish version of the Nottingham Health Profile: a review of adaptation and instrument characteristics.

Authors:  J Alonso; L Prieto; J M Antó
Journal:  Qual Life Res       Date:  1994-12       Impact factor: 4.147

7.  Crack-cocaine use and health status as defined by the SF-36.

Authors:  R S Falck; J Wang; R G Carlson; H A Siegal
Journal:  Addict Behav       Date:  2000 Jul-Aug       Impact factor: 3.913

8.  Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment.

Authors:  V L King; M S Kidorf; K B Stoller; R K Brooner
Journal:  J Addict Dis       Date:  2000

9.  The impact of comorbid anxiety and depression on alcohol treatment outcomes.

Authors:  Lucy Burns; Maree Teesson; Katy O'Neill
Journal:  Addiction       Date:  2005-06       Impact factor: 6.526

10.  Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Deborah S Hasin; Frederick S Stinson; Elizabeth Ogburn; Bridget F Grant
Journal:  Arch Gen Psychiatry       Date:  2007-07
View more
  9 in total

1.  Testing Genetic and Environmental Associations Between Personality Disorders and Cocaine Use: A Population-Based Twin Study.

Authors:  Nathan A Gillespie; Steven H Aggen; Amanda E Gentry; Michael C Neale; Gun P Knudsen; Robert F Krueger; Susan C South; Nikolai Czajkowski; Ragnar Nesvåg; Eivind Ystrom; Tom H Rosenström; Fartein A Torvik; Ted Reichborn-Kjennerud; Kenneth S Kendler
Journal:  Twin Res Hum Genet       Date:  2018-02       Impact factor: 1.587

2.  Association of current and past opioid use disorders with health-related quality of life and employment among US adults.

Authors:  Taeho Greg Rhee; Robert A Rosenheck
Journal:  Drug Alcohol Depend       Date:  2019-04-23       Impact factor: 4.492

3.  The role of dual diagnosis in health-related quality of life among treatment-seeking patients in Spain.

Authors:  Constanza Daigre; Lara Grau-López; Laia Rodríguez-Cintas; Elena Ros-Cucurull; Marta Sorribes-Puertas; Oriol Esculies; Katia Bones-Rocha; Carlos Roncero
Journal:  Qual Life Res       Date:  2017-08-07       Impact factor: 4.147

4.  Mental Disorders Are Associated With Leukocytes Telomere Shortening Among People Who Inject Drugs.

Authors:  Mélusine Durand; Nicolas Nagot; Laurent Michel; Sao Mai Le; Huong Thi Duong; Roselyne Vallo; Amélie Vizeneux; Delphine Rapoud; Hoang Thi Giang; Catherine Quillet; Nham Thi Tuyet Thanh; Khuat Thi Hai Oanh; Vu Hai Vinh; Jonathan Feelemyer; Philippe Vande Perre; Khue Pham Minh; Didier Laureillard; Don Des Jarlais; Jean-Pierre Molès
Journal:  Front Psychiatry       Date:  2022-06-17       Impact factor: 5.435

5.  Evaluation of plasma cytokines in patients with cocaine use disorders in abstinence identifies transforming growth factor alpha (TGFα) as a potential biomarker of consumption and dual diagnosis.

Authors:  Rosa Maza-Quiroga; Nuria García-Marchena; Pablo Romero-Sanchiz; Pedro Araos; Vicente Barrios; María Pedraz; Antonia Serrano; Raquel Nogueira-Arjona; Juan Jesus Ruiz; Maribel Soria; Rafael Campos; Julie Ann Chowen; Jesus Argente; Marta Torrens; Meritxell López-Gallardo; Eva María Marco; Fernando Rodríguez de Fonseca; Francisco Javier Pavón
Journal:  PeerJ       Date:  2017-10-12       Impact factor: 2.984

6.  Comparison of health-related quality of life among men with different co-existing severe mental disorders in treatment for substance use.

Authors:  Ana Adan; Julia E Marquez-Arrico; Gail Gilchrist
Journal:  Health Qual Life Outcomes       Date:  2017-10-23       Impact factor: 3.186

7.  Assessing the validity and reliability of the Turkish versions of craving beliefs and beliefs about substance use questionnaire in patients with heroin use disorder: demonstrating valid tools to assess cognition-emotion interplay.

Authors:  Melike Küçükkarapınar; Hale Yapici Eser; Vahap Ozan Kotan; Merve Yalcinay-Inan; Rifat Tarhan; Zehra Arikan
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-08-22

8.  Dual Disorders in the Consultation Liaison Addiction Service: Gender Perspective and Quality of Life.

Authors:  Teresa Ferrer-Farré; Fernando Dinamarca; Joan Ignasi Mestre-Pintó; Francina Fonseca; Marta Torrens
Journal:  J Clin Med       Date:  2021-11-26       Impact factor: 4.241

9.  Health Related Quality of Life in Individuals Transferred from a Needle Exchange Program and Starting Opioid Agonist Treatment.

Authors:  Martin Bråbäck; Louise Brådvik; Katja Troberg; Pernilla Isendahl; Suzan Nilsson; Anders Håkansson
Journal:  J Addict       Date:  2018-12-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.